BISOLVON

This brand name is authorized in Austria, Brazil, Germany, Ecuador, Finland, France, Croatia, Ireland, Japan, Malta, Mexico, Netherlands, New Zealand, United Kingdom, South Africa

Active ingredients

The drug BISOLVON contains one active pharmaceutical ingredient (API):

1 Bromhexine UNII YC2ZOM3Z8V - BROMHEXINE HYDROCHLORIDE

Bromhexine is an expectorant used in the treatment of respiratory disorders associated with viscid or excessive mucus. Bromhexine is a synthetic derivative of the herbal active ingredient vasicine. It has been shown to increase the proportion of serous bronchial secretion, making it more easily expectorated. It is indicated as “secretolytic therapy in bronchopulmonary diseases associated with abnormal mucus secretion and impaired mucus transport”. Read about Bromhexine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
BISOLVON Oral solution	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R05CB02	Bromhexine	R Respiratory system → R05 Cough and cold preparations → R05C Expectorants, excl. combinations with cough suppressants → R05CB Mucolytics
Discover more medicines within R05CB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 576720050070817, 576720050070917, 576720050071017
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00139011, 07706855
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 4383-MEE-0918, 4481-MEE-1118, 4528-MEE-0119
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 034367, 045051, 112976, 420976
Country: FR	Base de données publique des médicaments	Identifier(s): 61360073
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 246171
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-025912186, HR-H-042974735, HR-H-667277868
Country: IE	Health Products Regulatory Authority	Identifier(s): 15328
Country: JP	医薬品医療機器総合機構	Identifier(s): 2234001F1312, 2234400A1062, 2234700G1051
Country: MT	Medicines Authority	Identifier(s): MA1470/00101, PI1438/04401A, PI908/05701A
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 73688, 78884
Country: NL	Z-Index G-Standaard	Identifier(s): 12357782, 12515140, 13529919, 14049430
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 1325, 16810, 17922, 46108
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 491, 493
Country: ZA	Health Products Regulatory Authority	Identifier(s): C/10.1/66